Aeterna Zentaris
AEZS
#10376
Rank
HK$0.13 B
Marketcap
HK$44.82
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -HK$16.03

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -HK$16.06. In 2022 the company made an earnings per share (EPS) of -HK$36.67 a decrease over its 2021 EPS that were of -HK$14.26.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$16.03
2022-HK$36.67157.14%
2021-HK$14.26-41.48%
2020-HK$24.37-64.46%
2019-HK$68.56-240%
2018HK$48.97-122.32%
2017-HK$219.41-53.53%
2016-HK$472.12-86.71%
2015-HK$3,554-35.21%
2014-HK$5,485-216.67%
2013HK$4,702-123.3%
2012-HK$20,178-40.8%
2011-HK$34,087-6.45%
2010-HK$36,437-27.91%
2009-HK$50,542-61.61%
2008-HK$131,64583.61%
2007-HK$71,699-195.31%
2006HK$75,225178.26%
2005HK$27,034-330%
2004-HK$11,754-80.05%
2003-HK$58,91617.78%
2002-HK$50,023515.93%
2001-HK$8,122-68.6%
2000-HK$25,867119.62%
1999-HK$11,778-3.63%
1998-HK$12,222

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$55.01-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$20.06-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$27.90-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$20.45-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA